Diantra

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LACKS FIRM2 refused lines

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• UNSFDIETLB1 refused line

  UNSFDIETLB

• UNSFDIETSP1 refused line

  Dietary ingredient without safety assurance

  The product appeared to be a dietary supplement or dietary ingredient for which there is inadequate information to provide reasonable assurance that it does not present a significant or unreasonable risk of illness or injury.

Questions about Diantra

Is Diantra on an FDA import alert?

No listing for Diantra appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the Indonesia page.

Has FDA refused shipments from Diantra?

Yes. FDA refused 3 shipment lines from Diantra between September 28, 2020 and April 20, 2021. The most recent, on April 20, 2021, was kratom (herbal and botanical teas ii, continued), charged as UNSFDIETLB (unsfdietlb).

Why did FDA refuse Diantra's shipments?

The most frequent charges are LACKS FIRM (manufacturer name and address missing, 2 lines) and UNAPPROVED (unapproved new drug, 1 line).

What is Diantra's FEI number?

Diantra's FDA Establishment Identifier (FEI) is 3017109025.